Intage Holdings Inc
TSE:4326

Watchlist Manager
Intage Holdings Inc Logo
Intage Holdings Inc
TSE:4326
Watchlist
Price: 1 585 JPY -0.94% Market Closed
Market Cap: 60.4B JPY
Have any thoughts about
Intage Holdings Inc?
Write Note

Intage Holdings Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Intage Holdings Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Intage Holdings Inc
TSE:4326
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hakuhodo DY Holdings Inc
TSE:2433
Depreciation & Amortization
-ÂĄ13B
CAGR 3-Years
-17%
CAGR 5-Years
-14%
CAGR 10-Years
-27%
CyberAgent Inc
TSE:4751
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dentsu Group Inc
TSE:4324
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Macromill Inc
TSE:3978
Depreciation & Amortization
-ÂĄ2B
CAGR 3-Years
12%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Septeni Holdings Co Ltd
TSE:4293
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Intage Holdings Inc
Glance View

Market Cap
60.4B JPY
Industry
Media

INTAGE HOLDINGS, Inc. engages in the provision of marketing research and consulting services. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 3,080 full-time employees. The company went IPO on 2001-11-29. The Market Research and Consulting segment is engaged in marketing research operations, including customer panel research, retail shop panel research and other research activities; customized research services, including Internet research, mail survey, visiting interview survey and qualitative research, as well as the provision of related consulting services. The System Solution segment is engaged in the development and sale of software, the operation of systems and data centers, and the provision of various related consulting services. The Drug Development Support segment is engaged in the contract research organization (CRO) business. As of March 31, 2014, the Company had 24 subsidiaries and one associated company.

Intrinsic Value
1 823.88 JPY
Undervaluation 13%
Intrinsic Value
Price

See Also

Back to Top